sever
acut
respiratori
syndrom
sar
newli
emerg
infecti
diseas
usual
character
fever
dri
cough
myalgia
mild
sore
throat
progress
typic
pneumonia
sar
case
sarsrel
death
report
countri
around
world
http
wwwwhointcsrsarscountryen
sar
caus
newli
identifi
viru
within
famili
coronavirida
viru
design
sar
coronaviru
sarscov
rnai
natur
process
doublestrand
rna
direct
sequencespecif
silenc
homolog
gene
process
evolutionarili
conserv
found
wide
rang
eukaryot
organ
see
review
specif
inhibit
cellular
mrna
rnai
trigger
mammalian
cell
introduct
synthet
duplex
rna
sirna
discoveri
prompt
use
rnai
specif
inhibit
gene
express
replic
infecti
virus
replic
grow
number
human
pathogen
virus
cell
cultur
shown
inhibit
rnai
includ
polioviru
hcv
replicon
hepat
b
viru
influenza
viru
success
use
sirna
mammalian
cell
encourag
us
appli
rnai
explor
antisar
strategi
sarscov
envelop
singlestrand
plussens
rna
viru
genom
kb
sar
genom
encod
put
protein
typic
coronaviru
rep
spike
envelop
e
membran
nucleocapsid
n
structur
protein
e
n
common
known
coronaviru
play
role
host
cell
entri
viron
morphogenesi
releas
viron
assembl
n
bind
defin
packag
signal
viral
rna
form
helic
nucleocapsid
local
intracellular
membran
structur
interact
e
protein
nucleocapsid
result
bud
membran
structur
protein
attract
target
antisar
agent
develop
synthes
sirna
target
e
n
gene
sarscov
evalu
effect
viral
gene
express
vero
cell
conclud
synthet
sirna
could
effect
sequencespecif
downregul
sarscov
gene
express
dosedepend
manner
obtain
sirna
could
sequencespecif
reduc
target
gene
express
concentr
nm
sens
antisens
strand
sirna
oligonucleotid
synthes
anneal
min
follow
incub
h
anneal
buffer
ph
contain
mm
mg
ac
confirm
specif
inhibit
experi
includ
neg
control
sirna
duplex
direct
gene
sarscov
sirna
target
gene
use
neg
control
sirna
target
e
gene
tab
e
n
gene
express
vector
construct
donat
dr
youhua
xie
institut
biochemistri
cell
biolog
sib
ca
e
n
segment
releas
insert
ntermin
protein
fusion
mammalian
express
vector
clontech
gener
new
construct
pegfp
pegfpm
pegfpn
insert
sequenc
ensur
orient
correct
read
frame
vero
cell
cell
bank
institut
biochemistri
cell
biolog
sib
ca
cultur
dulbecco
modifi
eagl
medium
dmem
high
glucos
gibco
supplement
heat
inactiv
fetal
calf
serum
hyclon
transfect
sirna
duplex
plasmid
carri
plate
use
lipofectamin
reagent
invitrogen
accord
manufactur
instruct
nm
construct
nm
sirna
transient
transfect
vero
cell
viabil
cell
test
remov
cell
cultur
plate
count
haemocytomet
trypan
blue
stain
total
number
live
dead
cell
calcul
total
rna
cell
extract
use
trizol
reagent
invitrogen
digest
dnase
rnase
free
promega
min
dnase
heatinactiv
min
sequenc
primer
detect
e
gene
express
forward
revers
primer
gene
primer
n
gene
primer
singletub
onestep
rtpcr
perform
onestep
rna
pcr
kit
takara
reaction
mixtur
contain
extract
rna
mm
deoxynucleotid
triphosph
primer
mm
u
rnase
inhibitor
u
amv
revers
transcriptas
u
amvoptim
taq
initi
incub
min
follow
denatur
min
cycl
amplif
perform
use
thermo
profil
sec
sec
sec
final
cycl
includ
extens
min
amplif
product
analyz
electrophoresi
agaros
gel
stain
ethidium
bromid
vero
cell
seed
coverslipsmount
plate
cellswel
transfect
describ
h
cell
fix
freshli
made
paraformaldehyd
pb
min
room
temperatur
imag
use
olympu
fluoresc
microscop
object
field
randomli
chosen
sweep
across
coverslip
phase
contrast
illumin
randomli
chosen
field
differ
treat
cultur
experi
photograph
use
time
exposur
proport
vero
cell
express
gfp
fusion
protein
calcul
count
number
green
fluoresc
cell
total
number
cell
statist
analys
perform
use
student
ttest
p
valu
less
consid
statist
signific
sirna
design
target
open
read
frame
e
n
gene
sarscov
tab
target
sequenc
direct
singlestrand
region
fig
accord
secondari
structur
sarscov
rna
predict
use
rna
structur
sequenc
form
n
indic
nucleotid
gc
content
less
select
region
select
rna
follow
tt
synthes
chemic
institut
biochemistri
cell
biolog
sib
ca
first
evalu
sarsdirect
sirna
abil
suppress
sarscov
gene
express
vector
express
structur
protein
e
n
cotransfect
sirna
duplex
vero
cell
express
level
sarscov
gene
determin
h
later
rtpcr
result
show
sirna
duplex
specif
reduc
sarscov
gene
express
differ
extent
compar
control
fig
sirna
duplex
could
suppress
sarscov
gene
express
use
nm
fig
conduct
dose
respons
analysi
cotranst
fection
vero
cell
increas
amount
sirna
neg
control
sirna
togeth
sarscov
gene
express
level
h
posttransfect
measur
sirna
target
gene
use
neg
control
detect
e
gene
express
wherea
sirna
target
e
gene
use
neg
control
n
gene
sirna
duplex
dosedepend
inhibit
target
gene
express
rang
nm
fig
higher
dose
sirna
observ
slight
nonspecif
inhibitori
effect
neg
control
sirna
duplex
also
test
differ
toxic
sirna
duplex
set
use
nm
nm
nm
nm
nm
sirna
total
number
live
dead
cell
reveal
signific
differ
neg
control
sirna
sirna
treat
cultur
tab
indic
observ
downregul
sarscov
genesexpress
due
toxic
effect
duplex
kinet
studi
result
fig
reveal
continu
increas
specif
inhibit
sarscov
gene
express
sirna
h
transfect
inhibit
sarscov
gene
express
reach
maxim
h
start
declin
h
howev
effect
sirna
known
transient
could
last
day
confirm
effect
sirna
duplex
sarscov
gene
express
construct
vector
contain
exon
e
n
clone
frame
egfp
report
gene
cotransfect
vero
cell
vector
togeth
sirna
duplex
cell
examin
h
posttransfect
fluoresc
microscopi
microscop
examin
green
fluoresc
reveal
distinctli
reduc
express
fusion
protein
cell
treat
sirna
duplex
compar
cell
treat
neg
control
sirna
duplex
fig
recent
studi
suggest
thermodynam
properti
sirna
play
critic
role
determin
molecul
function
function
sirna
duplex
display
lower
intern
stabil
termin
base
pair
end
nonfunct
duplex
accord
rule
nucleotid
posit
sens
strand
sirna
duplex
exhibit
low
inhibit
activ
chang
unpair
end
antisens
strand
fig
mutat
sirna
duplex
transfect
vero
cell
togeth
express
vector
target
gene
express
level
measur
h
posttransfect
rtpcr
result
show
mutat
sirna
could
reduc
target
gene
express
effect
fig
mani
inact
sirna
duplex
may
brought
life
simpli
modifi
sens
strand
sirna
duplex
gene
silenc
mediat
doublestrand
rna
dsrna
sequencespecif
highli
conserv
mechan
eukaryot
plant
serv
antivir
defenc
mechan
recent
mammalian
rnai
machineri
success
program
sirna
target
viral
sequenc
induc
effect
antivir
respons
prompt
us
evalu
effect
sirna
sarscov
virus
especi
rna
virus
variabl
due
high
mutat
rate
replic
mutat
viral
protein
help
virus
escap
immunesystem
defenc
mechan
mutat
may
also
escap
attack
sirna
howev
emerg
escap
variant
resist
sirna
minim
use
sirna
direct
multipl
conserv
rna
target
sequenc
genom
sarscov
encod
put
protein
includ
four
major
structur
protein
nucleocapsid
n
spike
membran
small
envelop
e
play
essenti
role
host
cell
entri
viral
morphogenesi
releas
structur
protein
attract
target
antisar
agent
develop
among
protein
select
e
n
target
rnai
spike
protein
glycoprotein
project
viral
surfac
crucial
viral
attach
entri
host
cell
addit
variat
protein
among
strain
coronaviru
respons
host
rang
tissu
tropism
result
genet
sequenc
sampl
latest
patient
sar
show
variat
gene
sarscov
strain
sinc
subunit
spike
protein
major
antigen
moieti
coronavirus
essenti
structur
protein
prone
high
mutat
rate
viru
evolv
host
popul
therefor
nt
chose
protein
target
work
evalu
downregul
effect
sirna
duplex
target
differ
site
along
open
read
frame
e
n
protein
shown
fig
three
sirna
duplex
exhibit
inhibit
effici
sirna
duplex
show
inhibit
effici
sirna
duplex
reduc
target
gene
less
concentr
nm
modifi
sens
strand
sirna
duplex
shown
fig
inhibit
effici
mani
sirna
duplex
may
improv
combin
use
sirna
duplex
target
differ
region
viru
may
increas
effici
treatment
turn
prevent
appear
viral
revert
resist
treatment
human
coronavirus
usual
difficult
cultur
vitro
wherea
anim
coronavirus
sarscov
easili
cultur
african
green
monkey
kidney
vero
cell
direct
cytopath
effect
sarscov
could
demonstr
inocul
viral
isol
vero
cell
make
vero
cell
suitabl
model
studi
effect
sirna
duplex
sar
danger
high
morbid
mortal
rate
safe
conveni
studi
antisar
agent
use
vero
cell
transfect
sarscov
gene
express
vector
cell
model
obtain
sequencespecif
downregul
sarscov
gene
express
synthet
sirna
seen
result
rtpcr
fig
reduc
fluoresc
intens
egfp
sarscov
protein
e
n
fuse
fig
inhibit
dose
depend
rang
nm
sustain
administr
sirna
fig
addit
model
system
exploit
studi
patholog
function
sarscov
gene
present
sever
potenti
sar
therapi
develop
vaccin
interferon
use
rnai
therapi
sar
would
advantag
specif
target
gene
minim
side
effect
howev
interfer
sarscov
gene
express
induc
use
sirna
duplex
transient
essenti
prolong
express
sirna
ensur
deliveri
current
method
prolong
sirna
express
includ
use
plasmid
express
endogen
sirna
altern
approach
express
sirna
integr
viral
vector
achiev
continu
prolong
express
recent
articl
publish
prepar
work
report
antisar
activ
short
hairpin
rna
shrna
target
gene
express
promot
suggest
rnai
potenti
inhibit
replic
sarscov
infect
vero
cell
case
may
advantag
use
sirna
safeti
issu
regard
administr
foreign
dna
patient
conclus
show
sirna
could
design
induc
antivir
effect
sarscov
gene
express
cell
approach
might
provid
effect
therapeut
strategi
sarscov
infect
